Page last updated: 2024-11-05

xanthurenic acid and Anxiety Neuroses

xanthurenic acid has been researched along with Anxiety Neuroses in 2 studies

xanthurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by hydroxy groups at C-4 and C-8.

Research Excerpts

ExcerptRelevanceReference
" Herein we examined the effects of immune activation in association with tryptophan catabolite (TRYCAT) patterning and memory disorders on PHEMN/DAPS dimensions and MNP."3.91A New Schizophrenia Model: Immune Activation is Associated with the Induction of Different Neurotoxic Products which Together Determine Memory Impairments and Schizophrenia Symptom Dimensions. ( Carvalho, AF; Kanchanatawan, B; Maes, M; Sirivichayakul, S; Thika, S, 2019)
"Xanthurenic acid is a metabolite of L-tryptophanicotinic acid ribonucleotide biosynthesis."2.65The clinical significance of disordered renal excretion of xanthurenic acid in depressive patients. ( Hoes, MJ; Sijben, N, 1981)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sirivichayakul, S1
Kanchanatawan, B1
Thika, S1
Carvalho, AF1
Maes, M1
Hoes, MJ1
Sijben, N1

Trials

1 trial available for xanthurenic acid and Anxiety Neuroses

ArticleYear
The clinical significance of disordered renal excretion of xanthurenic acid in depressive patients.
    Psychopharmacology, 1981, Volume: 75, Issue:4

    Topics: 17-Hydroxycorticosteroids; Adult; Anxiety Disorders; Depressive Disorder; Female; Humans; Kynurenic

1981

Other Studies

1 other study available for xanthurenic acid and Anxiety Neuroses

ArticleYear
A New Schizophrenia Model: Immune Activation is Associated with the Induction of Different Neurotoxic Products which Together Determine Memory Impairments and Schizophrenia Symptom Dimensions.
    CNS & neurological disorders drug targets, 2019, Volume: 18, Issue:2

    Topics: Anxiety; Anxiety Disorders; Humans; Memory Disorders; Neuropsychological Tests; Schizophrenia; Trypt

2019